The Rheumatologist
COVID-19 NewsACR Convergence
  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed
  • Home
  • Conditions
    • Rheumatoid Arthritis
    • SLE (Lupus)
    • Crystal Arthritis
      • Gout Resource Center
    • Spondyloarthritis
    • Osteoarthritis
    • Soft Tissue Pain
    • Scleroderma
    • Vasculitis
    • Systemic Inflammatory Syndromes
    • Guidelines
  • Resource Centers
    • Axial Spondyloarthritis Resource Center
    • Gout Resource Center
    • Psoriatic Arthritis Resource Center
    • Rheumatoid Arthritis Resource Center
    • Systemic Lupus Erythematosus Resource Center
  • Drug Updates
    • Biologics & Biosimilars
    • DMARDs & Immunosuppressives
    • Topical Drugs
    • Analgesics
    • Safety
    • Pharma Co. News
  • Professional Topics
    • Ethics
    • Legal
    • Legislation & Advocacy
    • Career Development
      • Certification
      • Education & Training
    • Awards
    • Profiles
    • President’s Perspective
    • Rheuminations
    • Interprofessional Perspective
  • Practice Management
    • Billing/Coding
    • Quality Assurance/Improvement
    • Workforce
    • Facility
    • Patient Perspective
    • Electronic Health Records
    • Apps
    • Information Technology
    • From the College
    • Multimedia
      • Audio
      • Video
  • Resources
    • Issue Archives
    • ACR Convergence
      • Gout Resource Center
      • Axial Spondyloarthritis Resource Center
      • Psoriatic Arthritis
      • Abstracts
      • Meeting Reports
      • ACR Convergence Home
    • American College of Rheumatology
    • ACR ExamRheum
    • Research Reviews
    • ACR Journals
      • Arthritis & Rheumatology
      • Arthritis Care & Research
      • ACR Open Rheumatology
    • Rheumatology Image Library
    • Treatment Guidelines
    • Rheumatology Research Foundation
    • Events
  • About Us
    • Mission/Vision
    • Meet the Authors
    • Meet the Editors
    • Contribute to The Rheumatologist
    • Subscription
    • Contact
  • Advertise
  • Search
You are here: Home / Articles / Advocacy Up Close: Dr. Gary Bryant Discusses the Role & Benefits of RheumPAC

Advocacy Up Close: Dr. Gary Bryant Discusses the Role & Benefits of RheumPAC

April 18, 2019 • By Maura Iversen

  • Tweet
  • Email
Print-Friendly Version / Save PDF

[email protected]: What is the most effective form of advocacy?

You Might Also Like
  • RheumPAC Announces New Donor Benefits in 2020
  • RheumPAC Calls on the ACR, ARHP Members to Support Advocacy Efforts
  • Practices Now Contributing to RheumPAC
Explore This Issue
June 2019
Also By This Author
  • 2015 ACR/ARHP Annual Meeting to Offer Clinical Focus Course

Dr. Bryant: Advocacy is a combination of personal connections with legislators at the local, state or national level. That can entail participating in Capitol Hill visits or visiting local legislative offices. Many legislators appreciate local visits from their constituents. Our ability to show support and interest in legislators through conversations and through financial contributions is key to advancing our advocacy efforts. It is important to participate in advocacy both through contributions and by keeping abreast of ACR issues. The ACR website has an advocacy link where any member can gather information on current advocacy issues. Besides visiting local offices or going to events in the district, many rheumatologists and healthcare providers have invited legislators to their offices to see rheumatology care in action. These types of activities have a great impact.

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

[email protected]: How d0 you address concerns from members about where their money goes when they donate to RheumPAC?

Dr. Bryant: I emphasize that the decisions about the distribution of funds from RheumPAC is based on where a legislator stands on current ACR issues and whether that legislator holds a leadership position or key committee assignment. In addition, all contributions to candidates are first discussed and researched by RheumPAC, with assistance from ACR staff, before any vote is taken. These decisions are not based on whether the individual legislator is a Democrat, Republican or Independent. Finally, it is important to note that over time, the distribution of contributions to legislators eventually evens out among the political parties, depending on which party is in the majority. 

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

For More Information
If you are interested in joining your colleagues in rheumatology advocacy, visit rheumpac.org to learn more about current policy issues and RheumPAC.


Maura Iversen, BSc, PT, DPT, SD, MPH, is professor and chair of the Department of Physical Therapy, Movement and Rehabilitation Sciences at Northeastern University, a behavioral scientist in the Division of Rheumatology, Immunology, and Allergy at Brigham and Women’s Hospital, and a lecturer at Harvard Medical School, Boston.

Pages: 1 2 | Single Page

Filed Under: Legislation & Advocacy, Opinion, Rheuminations Tagged With: Gary Bryant, political action committee (PAC), rheumatology advocacy, RheumPACIssue: June 2019

You Might Also Like:
  • RheumPAC Announces New Donor Benefits in 2020
  • RheumPAC Calls on the ACR, ARHP Members to Support Advocacy Efforts
  • Practices Now Contributing to RheumPAC
  • RheumPAC Advocacy Fund: Effecting Change

About Maura Iversen

View more by this author»

Rheumatology Research Foundation

The Foundation is the largest private funding source for rheumatology research and training in the U.S.

Learn more »

Simple Tasks

Learn more about the ACR’s public awareness campaign and how you can get involved. Help increase visibility of rheumatic diseases and decrease the number of people left untreated.

Visit the Simple Tasks site »

ACR Convergence

Don’t miss rheumatology’s premier scientific meeting for anyone involved in research or the delivery of rheumatologic care or services.

Visit the ACR Convergence site »

The Rheumatologist newsmagazine reports on issues and trends in the management and treatment of rheumatic diseases. The Rheumatologist reaches 11,500 rheumatologists, internists, orthopedic surgeons, nurse practitioners, physician assistants, nurses, and other healthcare professionals who practice, research, or teach in the field of rheumatology.

About Us / Contact Us / Advertise / Privacy Policy / Terms of Use / Cookie Preferences

  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed

Copyright © 2006–2023 American College of Rheumatology. All rights reserved.

ISSN 1931-3268 (print)
ISSN 1931-3209 (online)